Insider · CIK 0001799360
Wendy Guy
Files at PCSA (Processa Pharmaceuticals, Inc.). First filing Apr 1, 2026, latest Jul 1, 2026.
In brief
Wendy Guy files SEC Form 4 as officer at PCSA (Processa Pharmaceuticals, Inc.). Since Apr 1, 2026, Wendy Guy has reported 7 open-market buys worth $33k and 0 open-market sells worth $0, the latest filed on Jul 1, 2026.
A track record needs three past buys with six months of prices behind them; Wendy Guy has 1, so none is measured yet.
The newest scored trade: bought $4,701 of PCSA on Jun 30, 2026, filed Jul 1, 2026, scored 59 (moderate). In the last 12 months: 7 buys worth $33k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PCSA: Processa Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 59Moderate | Processa Pharmaceuticals, Inc. | $4,701 2,436 shares | +20% | +4% from low-84% from high | |
| 49Moderate | Processa Pharmaceuticals, Inc. | $4,702 2,118 shares | +22% | +19% from low-82% from high | |
| 49Moderate | Processa Pharmaceuticals, Inc. | $4,701 1,829 shares | +23% | +38% from low-79% from high | |
| 49Moderate | Processa Pharmaceuticals, Inc. | $4,702 1,583 shares | +25% | +60% from low-75% from high | |
| 49Moderate | Processa Pharmaceuticals, Inc. | $4,702 1,748 shares | +37% | +46% from low-77% from high | |
| 53Moderate | Processa Pharmaceuticals, Inc. | $4,702 1,583 shares | +51% | +60% from low-75% from high | |
| 48Moderate | Processa Pharmaceuticals, Inc. | $4,700 1,854 shares | +148% | +36% from low-79% from high |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 26, 2026 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +9,450 | $0.00 | $0 | 11,669 | Jul 28, 2026 |
| Jun 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +2,436 | $1.93 | $4,701 | 14,394 | Jul 1, 2026 |
| Jun 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +2,118 | $2.22 | $4,702 | 11,958 | Jun 16, 2026 |
| May 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +1,829 | $2.57 | $4,701 | 9,840 | Jun 1, 2026 |
| May 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +1,583 | $2.97 | $4,702 | 8,011 | May 19, 2026 |
| Apr 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +1,748 | $2.69 | $4,702 | 6,441 | May 1, 2026 |
| Apr 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +1,583 | $2.97 | $4,702 | 4,693 | Apr 17, 2026 |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +1,854 | $2.54 | $4,700 | 3,110 | Apr 1, 2026 |
| Jan 1, 2026 | PCSA Processa Pharmaceuticals, Inc. | MOption exercise Common Stock | +193 | $0.00 | $0 | 1,256 | Feb 4, 2026 |
| Jan 1, 2026 | PCSA Processa Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -193 | $0.00 | $0 | 0 | Feb 4, 2026 |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +50,000 | $0.00 | $0 | 50,000 | Oct 3, 2025 |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Oct 3, 2025 |
| Jul 24, 2025 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +1,366,046 | $0.00 | $0 | 1,376,478 | Jul 28, 2025 |
| Apr 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | MOption exercise Common Stock | +14,482 | - | - | 26,339 | Apr 11, 2025 |
| Oct 12, 2023 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Common Stock | +14,771 | $0.34 | $5,022 | 202,517 | Oct 12, 2023 |
Questions about Wendy Guy
Answered from the filings on this page, as of the latest one.
Is Wendy Guy buying or selling?
In the last 12 months Wendy Guy reported 7 open-market buys worth $33k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $4,701 of PCSA on Jun 30, 2026. Grants, option exercises and tax withholding are not counted.
How did Wendy Guy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Wendy Guy has 1.
Where does Wendy Guy file Form 4?
Wendy Guy has filed Form 4 at PCSA (Processa Pharmaceuticals, Inc.) as Chief Administrative Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.